Last reviewed · How we verify

NCT03484559: IHCA

The Assessment of Survival After In-hospital Cardiac Arrest for 2 Years in Tertiary Hospital

Status unknown Last updated 25 May 2018
What this trial tests

trial in Cardiac Arrest in 450 participants. Status unknown.

Timeline
2 February 2018
Primary endpoint
30 May 2018
31 May 2018

Quick facts

Lead sponsorAydin Adnan Menderes University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment450
Start date2 February 2018
Primary completion30 May 2018
Estimated completion31 May 2018
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Aydin Adnan Menderes University

Who can join

Eligibility, any sex, with Cardiac Arrest. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Define the frequency and survival pattern of cardiac arrests in relation to the hospital day of event and etiology of arrest.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Survival after cardiopulmonary arrest in a tertiary care hospital in Turkey.
    Yilmaz S, Omurlu IK. · · 2019 · cited 4× · PMID 30905924 · DOI 10.5144/0256-4947.2019.07.03.1400

Verify or expand the search:

Other recruiting trials for Cardiac Arrest

Currently open trials in the same condition.

Other Aydin Adnan Menderes University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03484559.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing